Paramount Skydance Warner Bros Deal Faces UK Review
Paramount Skydance Warner Bros deal faces a UK media-plurality review while offering EU remedies, raising closing-timing risk and investor regulatory focus.

KEY TAKEAWAYS
- UK Culture Secretary was minded to intervene on media-plurality grounds, creating potential delay risk to closing.
- Paramount submitted remedies to the European Commission ahead of a July 22, 2026 decision deadline.
- Company said it remained confident in a Q3 2026 closing timeline despite ongoing state reviews.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
Paramount Skydance Warner Bros deal faces a potential UK public-interest review after Culture Secretary Lisa Nandy said she was minded to intervene, even as the company offered remedies to the European Commission and said it remained confident on its timeline.
Deal Size, Timing, and Regulatory Status
Paramount Skydance Corp. is pursuing a $110 billion acquisition of Warner Bros. Discovery. The company said it remains confident the transaction can close in the third quarter of 2026, its stated timeline. The U.S. Department of Justice has cleared the deal, while state attorneys general continue separate reviews.
UK Public-Interest Concerns and EU Remedies
Britain’s Culture Secretary Lisa Nandy said she was minded to intervene on public-interest and media-plurality grounds, citing the need for a sufficient plurality of views in news media and concerns about control of media enterprises. This signals a UK media-plurality review that would proceed on public-interest terms rather than conventional antitrust alone. If the government moves forward, Ofcom would conduct a public-interest assessment alongside a Competition and Markets Authority review, potentially delaying the deal beyond the company’s timeline.
Meanwhile, Paramount submitted remedies and commitments to the European Commission to address competition concerns. The Commission set a decision deadline of July 22, 2026, to either clear the transaction or open an in-depth probe. The filing of these remedies has increased the likelihood of EU approval.
Regulators must resolve the EU review by that deadline, while any formal UK public-interest intervention could complicate closing under the company’s stated timetable.





